BY STAKEHOLDER
Aimed Alliance’s New Report on AFPs: Navigating Today’s Pharmacy Benefits Efficiently, Effectively, and Ethically
The rising cost of healthcare, and prescription drugs in particular, is a source of anxiety for employers with each new…
Florida Bill to Regulate Hemp-Derived Products Advances
The Florida Senate recently voted to restrict the sale of intoxicating cannabinoid products. SB 1698 addresses health and safety concerns…
Aimed Alliance Submits Citizen Petition to the FDA on Alternative Funding Programs
On March 1, 2024, Aimed Alliance submitted a Citizen Petition to the Food and Drug Administration (FDA) regarding international importation…
Aimed Alliance Joins ERISA Comment to House Committee on Education and the Workforce
Aimed Alliance joined over forty advocacy organizations representing health care consumers and providers jointly submitted a letter on the Employee…
New Aimed Alliance Publication: Health Coverage of Certain Cannabis Products Poses Risks to Employers & Employees Alike
Policymakers Should Oppose Efforts to Mandate Coverage of Non-FDA-Approved Cannabis Products that Conflict with Federal Laws & Increase Risk of…
Aimed Alliance Sends Letter to Cigna Expressing Concerns Over $500 Debit Card Program
On May 14, 2021, Aimed Alliance sent a letter to Cigna to express concerns over its $500 debit card program.…
Alternative Funding Programs: The Cost Saving Program That Could Cost You
On March 20, 2023, Aimed Alliance released a new fact sheet titled “Alternative Funding Programs: The Cost Sharing Program That…
Healthy Equity in IBD Report Underscores Need For Community-Centered Solutions to Inequity
In 2022, Aimed Alliance recognized that health disparities exist in the inflammatory bowel disease (“IBD”) patient population. With rates of…
